AKT1 and lung cancer: Exogenous Tβ10 can promote the expression of VEGF-C mRNA and protein in lung cancer cell lines A549 and LK2 (P < 0.05), and this effect can be inhibited by use AKT inhibitor LY294002 (P < 0.05).